SEC Form 4 · accession 0001104659-19-003193
Rubius Therapeutics, Inc. · RUBY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher L. Carpenter
Officer — Chief Medical Officer
Period of report
Jan 22, 2019
Accepted (ET)
Jan 24, 2019 · 5:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001709401
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 22, 2019 | M | 34,843 | $2.87 | A | 34,843 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.87 | Jan 22, 2019 | M | 34,843 | D | — | Oct 24, 2027 | Common Stock | 34,843 | 715,157 | D |
Explanation of responses
- F125% of this option shall vest on September 18, 2018, then in 12 equal quarterly installments thereafter.